These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8648004)

  • 41. Elephantiasic pretibial myxedema and cutis verticis gyrata caused by Graves' disease.
    Bilen H; Atasoy M; Akcay G; Akcay M; Capoglu I; Gursan N; Akbas M
    Thyroid; 2006 Aug; 16(8):815-6. PubMed ID: 16910888
    [No Abstract]   [Full Text] [Related]  

  • 42. Lower extremity manifestations of Graves' disease.
    Sauer P; Brandes B; Mahmarian RR
    J Foot Ankle Surg; 1995; 34(5):489-97. PubMed ID: 8590885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An ultrastructural study of pretibial myxedema utilizing improved ruthenium red stain.
    Ishii M; Nakagawa K; Hamada T
    J Cutan Pathol; 1984 Apr; 11(2):125-31. PubMed ID: 6203946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema.
    Kamath C; Young S; Kabelis K; Sanders J; Adlan MA; Furmaniak J; Rees Smith B; Premawardhana LD
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):465-70. PubMed ID: 22891608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pretibial myxedema as the initial manifestation of Graves' disease.
    Georgala S; Katoulis AC; Georgala C; Katoulis EC; Hatziolou E; Stavrianeas NG
    J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):380-3. PubMed ID: 12224697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Refractory pretibial myxoedema with response to intralesional insulin-like growth factor 1 antagonist (octreotide): downregulation of hyaluronic acid production by the lesional fibroblasts.
    Shinohara M; Hamasaki Y; Katayama I
    Br J Dermatol; 2000 Nov; 143(5):1083-6. PubMed ID: 11069527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship of long-acting thyroid stimulator to pretibial myxedema.
    Schermer DR; Roenigk HH; Schumacher OP; McKenzie JM
    Arch Dermatol; 1970 Jul; 102(1):62-7. PubMed ID: 4925011
    [No Abstract]   [Full Text] [Related]  

  • 48. Annularly arranged nodular pretibial myxedema after 7-year treatment of Graves' disease.
    Kishimoto I; Chuyen NTH; Okamoto H
    J Dermatol; 2018 Jan; 45(1):110-111. PubMed ID: 28150342
    [No Abstract]   [Full Text] [Related]  

  • 49. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
    Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema.
    Chang CC; Chang TC; Kao SC; Kuo YF; Chien LF
    Acta Endocrinol (Copenh); 1993 Oct; 129(4):322-7. PubMed ID: 8237250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Euthyroid pretibial myxedema and EMO syndrome.
    Senel E; Güleç AT
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Mar; 18(1):21-3. PubMed ID: 19350184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease.
    Kemp EH; Ridgway JN; Smith KA; Watson PF; Weetman AP
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):291-9. PubMed ID: 10971445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elephantiasic pretibial myxedema in Graves' disease.
    Sharma VK; Sood A; Sood A; Singh MK
    J Assoc Physicians India; 2002 Nov; 50():1430-1. PubMed ID: 12583477
    [No Abstract]   [Full Text] [Related]  

  • 54. Successful therapeutic approach in a patient with elephantiasic pretibial myxedema.
    Ferreira M; Zacaron LH; Valle AFD; Gamonal ACC
    An Bras Dermatol; 2020; 95(4):469-472. PubMed ID: 32461007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Echographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease.
    Salvi M; De Chiara F; Gardini E; Minelli R; Bianconi L; Alinovi A; Ricci R; Neri F; Tosi C; Roti E
    Eur J Endocrinol; 1994 Aug; 131(2):113-9. PubMed ID: 8075779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dermacase. Pretibial myxedema.
    Prajapati VH; Mydlarski PR
    Can Fam Physician; 2008 Mar; 54(3):357, 369. PubMed ID: 18337527
    [No Abstract]   [Full Text] [Related]  

  • 57. Pretibial myxedema.
    Kapoor R; Sethi A
    J Hosp Med; 2010 Jan; 5(1):59. PubMed ID: 20063273
    [No Abstract]   [Full Text] [Related]  

  • 58. Pretibial myxedema.
    Chung-Leddon J
    Dermatol Online J; 2001 Feb; 7(1):18. PubMed ID: 11328639
    [No Abstract]   [Full Text] [Related]  

  • 59. Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts.
    Heufelder AE; Wenzel BE; Bahn RS
    J Clin Endocrinol Metab; 1992 Apr; 74(4):737-42. PubMed ID: 1532179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response to topical halcinonide following fractional carbon dioxide laser pretreatment in a pretibial myxedema patient.
    Xu Y; Ma R; Cai Y; Zheng X
    Indian J Dermatol Venereol Leprol; 2018; 84(6):763. PubMed ID: 29363626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.